Cargando…

Correction: Bumetanide Enhances Phenobarbital Efficacy in a Rat Model of Hypoxic Neonatal Seizures

Detalles Bibliográficos
Autores principales:	Cleary, Ryan T., Sun, Hongyu, Huynh, Thanhthao, Manning, Simon M., Li, Yijun, Rotenberg, Alexander, Talos, Delia M., Kahle, Kristopher T., Jackson, Michele, Rakhade, Sanjay N., Berry, Gerard T., Jensen, Frances E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3778036/ http://dx.doi.org/10.1371/annotation/48a011e6-e4d0-4706-9a28-857eba8cfb31

Ejemplares similares

Bumetanide Enhances Phenobarbital Efficacy in a Rat Model of Hypoxic Neonatal Seizures
por: Cleary, Ryan T., et al.
Publicado: (2013)

Effect of Co-administration of Bumetanide and Phenobarbital on Seizure Attacks in Temporal Lobe Epilepsy
por: Rahmanzadeh, Reza, et al.
Publicado: (2018)

Gene Expression Profiling of a Hypoxic Seizure Model of Epilepsy Suggests a Role for mTOR and Wnt Signaling in Epileptogenesis
por: Theilhaber, Joachim, et al.
Publicado: (2013)

Bumetanide for neonatal seizures: No light in the pharmacokinetic/dynamic tunnel
por: Kaila, Kai, et al.
Publicado: (2022)

Ganaxolone versus Phenobarbital for Neonatal Seizure Management
por: Miller, Suzanne L., et al.
Publicado: (2022)

Don’t Get BUM’d Out: Bumetanide May yet Prove Beneficial for Neonatal Seizures
por: Stafstrom, Carl E.
Publicado: (2021)

Phenobarbital reduces EEG amplitude and propagation of neonatal seizures but does not alter performance of automated seizure detection
por: Mathieson, Sean R., et al.
Publicado: (2016)

Failure of the Nemo Trial: Bumetanide Is a Promising Agent to Treat Many Brain Disorders but Not Newborn Seizures
por: Ben-Ari, Yehezkel, et al.
Publicado: (2016)

Adverse neurodevelopmental outcomes after exposure to phenobarbital and levetiracetam for the treatment of neonatal seizures
por: Maitre, Nathalie L, et al.
Publicado: (2013)

Intravenous levetiracetam versus phenobarbital in children with status epilepticus or acute repetitive seizures
por: Lee, Yun-Jeong, et al.
Publicado: (2016)

New nanocarried phenobarbital formulation: Maintains better control of pentylenetetrazole-Induced seizures
por: de Almeida, Lorena Cristina Nunes, et al.
Publicado: (2020)

Cost-Effectiveness Analysis of Topiramate versus Phenobarbital in the Treatment of Children with Febrile Seizure
por: NEMATI, Hamid, et al.
Publicado: (2019)

Evading Seizures: Phenobarbital Reintroduced as a Multifunctional Approach to End-of-Life Care
por: Senderovich, Helen, et al.
Publicado: (2022)

Bumetanide: Metabolic alkalosis: case report
Publicado: (2021)

Complex spectrum of phenobarbital effects in a mouse model of neonatal hypoxia-induced seizures
por: Quinlan, Sean M. M., et al.
Publicado: (2018)

A Comparative Study of Levetiracetam and Phenobarbital for Neonatal Seizures as a First Line Treatment
por: Akeel, Nagwa Elsayed, et al.
Publicado: (2022)

Bumetanide Exposure Association with Alzheimer’s Disease Risk
por: Graber-Naidich, Anna, et al.
Publicado: (2023)

Age- and sex-dependent susceptibility to phenobarbital-resistant neonatal seizures: role of chloride co-transporters
por: Kang, Seok Kyu, et al.
Publicado: (2015)

Phenobarbital and neonatal seizures affect cerebral oxygen metabolism: a near-infrared spectroscopy study
por: Sokoloff, Max D., et al.
Publicado: (2015)

Dose-dependent reversal of KCC2 hypofunction and phenobarbital-resistant neonatal seizures by ANA12
por: Carter, B. M., et al.
Publicado: (2018)

Efficacy and Safety of Levetiracetam vs. Phenobarbital for Neonatal Seizures: A Systematic Review and Meta-Analysis
por: Qiao, Meng-Yuan, et al.
Publicado: (2021)

Nebivolol attenuates the anticonvulsant action of carbamazepine and phenobarbital against the maximal electroshock-induced seizures in mice
por: Borowicz-Reutt, Kinga K., et al.
Publicado: (2019)

Pharmacotherapeutic targeting of cation-chloride cotransporters in neonatal seizures
por: Puskarjov, Martin, et al.
Publicado: (2014)

Off-Label Use of Bumetanide for Brain Disorders: An Overview
por: Kharod, Shivani C., et al.
Publicado: (2019)

Bumetanide for autism: Open‐label trial in six children
por: Fernell, Elisabeth, et al.
Publicado: (2021)

Intermittent Diazepam versus Continuous Phenobarbital to Prevent Recurrence of Febrile Seizures: A Randomized Controlled Trial
por: SALEHIOMRAN, Mohammadreza, et al.
Publicado: (2016)

Correction to: Nebivolol attenuates the anticonvulsant action of carbamazepine and phenobarbital against the maximal electroshock-induced seizures in mice
por: Borowicz-Reutt, Kinga K., et al.
Publicado: (2021)

Use of Phenobarbital in Delirium Tremens
por: Fujimoto, Jeffrey, et al.
Publicado: (2017)

Pharmacokinetics and Optimal Dosing of Phenobarbital
por: Shareef, Safiullah, et al.
Publicado: (2018)

A randomised controlled trial of bumetanide in the treatment of autism in children
por: Lemonnier, E, et al.
Publicado: (2012)

Bumetanide for autism: more eye contact, less amygdala activation
por: Hadjikhani, Nouchine, et al.
Publicado: (2018)

Failure of bumetanide to improve outcome after intracerebral hemorrhage in rat
por: Wilkinson, Cassandra M., et al.
Publicado: (2019)

Bumetanide Prevents Brain Trauma-Induced Depressive-Like Behavior
por: Goubert, Emmanuelle, et al.
Publicado: (2019)

Albumin human/bumetanide: Osmotic demyelination syndrome: case report
Publicado: (2020)

Evaluation of bumetanide as a potential therapeutic agent for Alzheimer’s disease
por: Boyarko, Ben, et al.
Publicado: (2023)

Limitations of Current GABA Agonists in Neonatal Seizures: Toward GABA Modulation Via the Targeting of Neuronal Cl(−) Transport
por: Khanna, Arjun, et al.
Publicado: (2013)

Discovery of E2730, a novel selective uncompetitive GAT1 inhibitor, as a candidate for anti‐seizure medication
por: Fukushima, Kazuyuki, et al.
Publicado: (2023)

A retrospective evaluation of the efficacy of intravenous bumetanide and comparison of potency with furosemide
por: Nappi, Jean M.
Publicado: (2013)

Bumetanide As a Candidate Treatment for Behavioral Problems in Tuberous Sclerosis Complex
por: Vlaskamp, Chantal, et al.
Publicado: (2017)

Longitudinal Effects of Bumetanide on Neuro-Cognitive Functioning in Drug-Resistant Epilepsy
por: Gharaylou, Zeinab, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_0in9ioi7d357h6fb0dgli9fcuv